vs
Side-by-side financial comparison of MEDALLION FINANCIAL CORP (MFIN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $70.6M, roughly 1.2× MEDALLION FINANCIAL CORP). MEDALLION FINANCIAL CORP runs the higher net margin — 17.3% vs -38.1%, a 55.3% gap on every dollar of revenue. On growth, MEDALLION FINANCIAL CORP posted the faster year-over-year revenue change (25.4% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 15.0%).
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
MFIN vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $70.6M | $83.1M |
| Net Profit | $12.2M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 29.3% | -4.1% |
| Net Margin | 17.3% | -38.1% |
| Revenue YoY | 25.4% | 20.2% |
| Net Profit YoY | 20.3% | -27.9% |
| EPS (diluted) | $0.50 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $70.6M | $76.4M | ||
| Q3 25 | $58.7M | $83.3M | ||
| Q2 25 | $62.6M | $79.2M | ||
| Q1 25 | $63.0M | $69.2M | ||
| Q4 24 | $56.3M | $68.2M | ||
| Q3 24 | $53.3M | $58.4M | ||
| Q2 24 | $51.0M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $12.2M | $-29.8M | ||
| Q3 25 | $7.8M | $-21.4M | ||
| Q2 25 | $11.1M | $-19.6M | ||
| Q1 25 | $12.0M | $-24.7M | ||
| Q4 24 | $10.1M | $-18.9M | ||
| Q3 24 | $8.6M | $-21.0M | ||
| Q2 24 | $7.1M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 29.3% | -40.6% | ||
| Q3 25 | 33.2% | -27.8% | ||
| Q2 25 | 31.1% | -28.0% | ||
| Q1 25 | 32.1% | -39.7% | ||
| Q4 24 | 32.8% | -28.9% | ||
| Q3 24 | 26.6% | -38.4% | ||
| Q2 24 | 24.3% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 17.3% | -39.1% | ||
| Q3 25 | 13.2% | -25.7% | ||
| Q2 25 | 17.7% | -24.7% | ||
| Q1 25 | 19.1% | -35.8% | ||
| Q4 24 | 18.0% | -27.6% | ||
| Q3 24 | 16.1% | -35.9% | ||
| Q2 24 | 13.9% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.50 | $-0.54 | ||
| Q3 25 | $0.32 | $-0.38 | ||
| Q2 25 | $0.46 | $-0.35 | ||
| Q1 25 | $0.50 | $-0.45 | ||
| Q4 24 | $0.43 | $-0.34 | ||
| Q3 24 | $0.37 | $-0.40 | ||
| Q2 24 | $0.30 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.3M | $245.6M |
| Total DebtLower is stronger | $216.0M | $51.7M |
| Stockholders' EquityBook value | $408.6M | $347.7M |
| Total Assets | $3.0B | $487.1M |
| Debt / EquityLower = less leverage | 0.53× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $136.3M | $286.5M | ||
| Q3 25 | $72.5M | $294.3M | ||
| Q2 25 | $110.4M | $302.7M | ||
| Q1 25 | $131.5M | $316.2M | ||
| Q4 24 | $98.2M | $333.7M | ||
| Q3 24 | $120.6M | $196.8M | ||
| Q2 24 | $87.7M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $216.0M | $51.6M | ||
| Q3 25 | $215.7M | $51.6M | ||
| Q2 25 | $199.9M | $51.5M | ||
| Q1 25 | $199.7M | $51.5M | ||
| Q4 24 | $232.2M | $51.5M | ||
| Q3 24 | $232.0M | $51.4M | ||
| Q2 24 | $230.8M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $408.6M | $365.9M | ||
| Q3 25 | $397.4M | $380.3M | ||
| Q2 25 | $389.9M | $385.8M | ||
| Q1 25 | $380.2M | $389.2M | ||
| Q4 24 | $370.2M | $402.2M | ||
| Q3 24 | $362.4M | $241.2M | ||
| Q2 24 | $354.0M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $3.0B | $508.1M | ||
| Q3 25 | $2.9B | $511.5M | ||
| Q2 25 | $2.9B | $513.1M | ||
| Q1 25 | $2.8B | $519.4M | ||
| Q4 24 | $2.9B | $534.0M | ||
| Q3 24 | $2.9B | $374.1M | ||
| Q2 24 | $2.8B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.53× | 0.14× | ||
| Q3 25 | 0.54× | 0.14× | ||
| Q2 25 | 0.51× | 0.13× | ||
| Q1 25 | 0.53× | 0.13× | ||
| Q4 24 | 0.63× | 0.13× | ||
| Q3 24 | 0.64× | 0.21× | ||
| Q2 24 | 0.65× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 10.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $126.3M | $-10.3M | ||
| Q3 25 | $67.0M | $-6.6M | ||
| Q2 25 | $-10.7M | $-15.0M | ||
| Q1 25 | $36.3M | $-17.0M | ||
| Q4 24 | $108.7M | $-32.4M | ||
| Q3 24 | $24.6M | $-18.8M | ||
| Q2 24 | $27.6M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 10.35× | — | ||
| Q3 25 | 8.63× | — | ||
| Q2 25 | -0.97× | — | ||
| Q1 25 | 3.02× | — | ||
| Q4 24 | 10.72× | — | ||
| Q3 24 | 2.86× | — | ||
| Q2 24 | 3.89× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MFIN
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
